Lina Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lina Liang has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Kai Xu
Department of Eye Function Laboratory, Eye Hospital China Academy of Chinese Medical Sciences
10 shared publicationsYamin Li
Department of Eye Function Laboratory, Eye Hospital China Academy of Chinese Medical Sciences
10 shared publicationsJiaxian Li
Department of Ophthalmology, The First Affiliated Hospital of Yunnan University of Chinese Medicine, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, China
9 shared publicationsYu Jin
Department of ophthalmology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong, China
7 shared publicationsWei Zhou
Department of Eye Function Laboratory, Eye Hospital, China Academy of Chinese Medical Sciences, China
6 shared publicationsXiaoyu Li
Eye Hospital, China Academy of Chinese Medical Sciences, Beijing, China
5 shared publications
Latest Publications
- 20 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1215
Correction: Ginkgo biloba extract as a retinal protective agent: a systematic review of preclinical experiments
- 20 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1215
Correction: Ginkgo biloba extract as a retinal protective agent: a systematic review of preclinical experiments
- Open Access
- 17 July 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1853872
Optimizing stimulation parameters: transpalpebral and transbrain electrical stimulation for retinal protection in RCS rats
Introduction: Retinitis pigmentosa is a genetically heterogeneous retinopathy causing photoreceptor death and blindness. Electrical stimulation is a promising non-invasive neuroprotective strategy. This study investigated the neuroprotective effects of transpalpebral ES (TpES) and transbrain ES (TbES) delivered at Gallbladder meridian acupoints (GB14, GB16, GB20) in Royal College of Surgeons (RCS) rats, and identified optimal parameters for each modality. Methods: RCS rats were randomized to control, sham, TpES (200, 400, 600, 800 µA), and TbES (15, 30, 50, 100 Hz) groups. Stimulation was given daily for 14 days from 6 weeks of age. Visual-guided behavior was assessed by open-field test (OFT). Retinal function and morphology were evaluated by electroretinography (ERG), color fundus photography (CFP), spectral-domain optical coherence tomography (SD-OCT), and histopathology. Photoreceptor apoptosis was quantified by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL). Neurotrophic factors (BDNF, CNTF, bFGF, NGF) and c-Fos were detected by immunofluorescence and digital PCR. Results: OFT revealed progressive anxiety-like behavior in untreated control rats, though non-visual confounds cannot be excluded. All stimulated groups exhibited stable locomotor activity comparable to sham, with no behavioral abnormalities or systemic adverse effects. All stimulated groups showed stable locomotor activity comparable to sham, with no adverse effects. TpES at 800 µA and TbES at 50 Hz produced the greatest preservation of retinal function and structure, maintaining 3–4 photoreceptor cell layers versus 1–2 layers in controls. TpES at 800 µA reduced the apoptotic index by ∼35%; all TbES frequencies lowered it to a similar range, indicating a frequency-independent anti-apoptotic threshold. Both modalities upregulated BDNF and bFGF; TbES—especially at 50 Hz—additionally upregulated CNTF and NGF, a pattern not seen in TpES groups. Elevated c-Fos confirmed inner retinal neuron activation. Conclusion: Optimized TpES (800 µA) and TbES (50 Hz) each exert neuroprotective effects, preserving retinal function and structure, reducing apoptosis, and upregulating neurotrophic factors, without behavioral or systemic side effects. These eye-brain ES approaches, grounded in traditional Chinese medicine meridian theory and modern neuromodulation, provide evidence-based parameters for clinical translation and represent a promising synergistic strategy.
- 17 July 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1853872
Open AccessOptimizing stimulation parameters: transpalpebral and transbrain electrical stimulation for retinal protection in RCS rats
Introduction: Retinitis pigmentosa is a genetically heterogeneous retinopathy causing photoreceptor death and blindness. Electrical stimulation is a promising non-invasive neuroprotective strategy. This study investigated the neuroprotective effects of transpalpebral ES (TpES) and transbrain ES (TbES) delivered at Gallbladder meridian acupoints (GB14, GB16, GB20) in Royal College of Surgeons (RCS) rats, and identified optimal parameters for each modality. Methods: RCS rats were randomized to control, sham, TpES (200, 400, 600, 800 µA), and TbES (15, 30, 50, 100 Hz) groups. Stimulation was given daily for 14 days from 6 weeks of age. Visual-guided behavior was assessed by open-field test (OFT). Retinal function and morphology were evaluated by electroretinography (ERG), color fundus photography (CFP), spectral-domain optical coherence tomography (SD-OCT), and histopathology. Photoreceptor apoptosis was quantified by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL). Neurotrophic factors (BDNF, CNTF, bFGF, NGF) and c-Fos were detected by immunofluorescence and digital PCR. Results: OFT revealed progressive anxiety-like behavior in untreated control rats, though non-visual confounds cannot be excluded. All stimulated groups exhibited stable locomotor activity comparable to sham, with no behavioral abnormalities or systemic adverse effects. All stimulated groups showed stable locomotor activity comparable to sham, with no adverse effects. TpES at 800 µA and TbES at 50 Hz produced the greatest preservation of retinal function and structure, maintaining 3–4 photoreceptor cell layers versus 1–2 layers in controls. TpES at 800 µA reduced the apoptotic index by ∼35%; all TbES frequencies lowered it to a similar range, indicating a frequency-independent anti-apoptotic threshold. Both modalities upregulated BDNF and bFGF; TbES—especially at 50 Hz—additionally upregulated CNTF and NGF, a pattern not seen in TpES groups. Elevated c-Fos confirmed inner retinal neuron activation. Conclusion: Optimized TpES (800 µA) and TbES (50 Hz) each exert neuroprotective effects, preserving retinal function and structure, reducing apoptosis, and upregulating neurotrophic factors, without behavioral or systemic side effects. These eye-brain ES approaches, grounded in traditional Chinese medicine meridian theory and modern neuromodulation, provide evidence-based parameters for clinical translation and represent a promising synergistic strategy.
- 30 June 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Ginkgo biloba extract as a retinal protective agent: a systematic review of preclinical experiments
Ginkgo biloba extract (EGb), a complementary and alternative medicinal option, has gained extensive application in addressing conditions like cerebrovascular and peripheral vascular disorders. We aim to assess the neuroprotective efficacy of EGb for retinal disorders and to clarify its potential mechanisms of action through a systematic review. We searched original literature about laboratory experiments from four databases which were released until April 2024. The methodological quality of included in vivo studies was assessed using the SYRCLE risk of bias tool. The results showed that out of the 398 studies initially collected, 26 articles met the requirements for full-text review. 20 of them presented in vivo data, 2 detailed both in vitro and in vivo evidence, and 4 were in vitro experiments. Results demonstrated the protective effects of EGb against several retinal disorders, including retinal ganglion cell injury, retinal degeneration, ischemia, vitreo- or pre-retinal proliferative disorder, uveitis, and diabetic retinopathy. Based on SYRCLE's evaluation of bias risk, the in vivo studies' quality scores varied from 4 to 7 points. The data indicated that EGb preserved visual function by maintaining retinal morphology and structure in preclinical models. Its action mechanism may be associated with suppressing apoptosis, attenuating oxidative stress, reducing inflammation, inhibiting angiogenesis, and suppressing proteolysis. These preclinical findings suggest that EGb may be a promising neuroprotective agent for retinal disorders. However, the methodological limitations of the included studies necessitate cautious interpretation; to demonstrate the effectiveness and safety of EGb, more extensive clinical randomized controlled trials are required.
- 30 June 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Ginkgo biloba extract as a retinal protective agent: a systematic review of preclinical experiments
Ginkgo biloba extract (EGb), a complementary and alternative medicinal option, has gained extensive application in addressing conditions like cerebrovascular and peripheral vascular disorders. We aim to assess the neuroprotective efficacy of EGb for retinal disorders and to clarify its potential mechanisms of action through a systematic review. We searched original literature about laboratory experiments from four databases which were released until April 2024. The methodological quality of included in vivo studies was assessed using the SYRCLE risk of bias tool. The results showed that out of the 398 studies initially collected, 26 articles met the requirements for full-text review. 20 of them presented in vivo data, 2 detailed both in vitro and in vivo evidence, and 4 were in vitro experiments. Results demonstrated the protective effects of EGb against several retinal disorders, including retinal ganglion cell injury, retinal degeneration, ischemia, vitreo- or pre-retinal proliferative disorder, uveitis, and diabetic retinopathy. Based on SYRCLE's evaluation of bias risk, the in vivo studies' quality scores varied from 4 to 7 points. The data indicated that EGb preserved visual function by maintaining retinal morphology and structure in preclinical models. Its action mechanism may be associated with suppressing apoptosis, attenuating oxidative stress, reducing inflammation, inhibiting angiogenesis, and suppressing proteolysis. These preclinical findings suggest that EGb may be a promising neuroprotective agent for retinal disorders. However, the methodological limitations of the included studies necessitate cautious interpretation; to demonstrate the effectiveness and safety of EGb, more extensive clinical randomized controlled trials are required.
- Open Access
- 24 March 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1781217
Qiju Granule alleviates retinal damage in a mouse model of age-related macular degeneration
Background: Age-related macular degeneration (AMD) is the leading cause of visual loss in older people. Despite recent advances, the pathophysiology of AMD remains incompletely understood, and current therapies are limited. Qiju Granule is a traditional herbal formulation with therapeutic potential; however, its efficacy and mechanisms in AMD remain unclear. Objective: The aim of this study was to evaluate the protective effects of Qiju Granule in a mouse model of AMD and investigate potential underlying mechanisms. Methods: AMD-like retinal injury was induced in C57BL/6J mice by chronic light exposure combined with hydroquinone feeding. Retinal function and structure were assessed using electroretinography and histomorphological analyses. Retinal cell apoptosis and the expression of key angiogenic factors (VEGF and CD31) were assessed to explore underlying mechanisms. Results: Qiju Granule treatment significantly preserved retinal function, as reflected by improved electroretinographic responses, and maintained structural integrity of the retina and RPE layer. Mechanistically, Qiju Granule exerted potent anti-apoptotic effects, evidenced by a marked reduction in TUNEL-positive retinal cells. Furthermore, it downregulated VEGF and CD31 expression, indicating suppression of aberrant angiogenic signaling. Conclusion: Our findings identified a protective role of Qiju Granule in mitigating AMD-related retinal damage and suggested its potential as a therapeutic candidate to prevent progression to advanced AMD.
- 24 March 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1781217
Open AccessQiju Granule alleviates retinal damage in a mouse model of age-related macular degeneration
Background: Age-related macular degeneration (AMD) is the leading cause of visual loss in older people. Despite recent advances, the pathophysiology of AMD remains incompletely understood, and current therapies are limited. Qiju Granule is a traditional herbal formulation with therapeutic potential; however, its efficacy and mechanisms in AMD remain unclear. Objective: The aim of this study was to evaluate the protective effects of Qiju Granule in a mouse model of AMD and investigate potential underlying mechanisms. Methods: AMD-like retinal injury was induced in C57BL/6J mice by chronic light exposure combined with hydroquinone feeding. Retinal function and structure were assessed using electroretinography and histomorphological analyses. Retinal cell apoptosis and the expression of key angiogenic factors (VEGF and CD31) were assessed to explore underlying mechanisms. Results: Qiju Granule treatment significantly preserved retinal function, as reflected by improved electroretinographic responses, and maintained structural integrity of the retina and RPE layer. Mechanistically, Qiju Granule exerted potent anti-apoptotic effects, evidenced by a marked reduction in TUNEL-positive retinal cells. Furthermore, it downregulated VEGF and CD31 expression, indicating suppression of aberrant angiogenic signaling. Conclusion: Our findings identified a protective role of Qiju Granule in mitigating AMD-related retinal damage and suggested its potential as a therapeutic candidate to prevent progression to advanced AMD.
- Open Access
- 2 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17
Neuroinflammatory regulatory role of microglia in optic nerve injury: from pathological mechanisms to therapeutic targets
Optic nerve injury, encompassing conditions such as glaucoma, optic neuritis, and traumatic optic neuropathy, is a major cause of irreversible vision loss. Traditional broad-spectrum anti-inflammatory treatments have shown limited efficacy, highlighting the need for precision-based therapeutic approaches grounded in the underlying pathological mechanisms. As the primary immune cells of the central nervous system (CNS), microglia play a crucial role in regulating neuroinflammation following optic nerve injury. This review provides a comprehensive overview of the mechanisms governing microglial neuroinflammatory regulation, including early inflammatory signal recognition mediated by damage-associated molecular patterns (DAMPs), dynamic transcriptional networks regulating polarization between pro-inflammatory and pro-repair phenotypes, bidirectional modulation of phagocytic clearance by the complement system, and the complex multicellular interactions among microglia, astrocytes, and Müller cells. The concept of conditioning injury conditioning injury (intraocular inflammatory stimulation) has revealed the dual nature of neuroinflammatory responses: through temporal polarization shifts, microglia can both release neurotoxic mediators that worsen injury and secrete neurotrophic factors that promote axonal regeneration and myelin repair. This shift from traditional broad-spectrum anti-inflammatory strategies to precision functional modulation forms the basis for emerging therapeutic approaches, including PPARγ pathway activation, selective complement system targeting, and time-dependent modulation. We also assess the potential of advanced technologies, such as nanodelivery systems, single-cell analysis, and molecular imaging, in precision diagnosis and treatment. Finally, we critically examine the limitations of current research, including interspecies variability, model constraints, and clinical translation barriers, and discuss the translational potential of microglia-targeted therapies in protecting and restoring clinically meaningful visual function.
- 2 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17
Open AccessNeuroinflammatory regulatory role of microglia in optic nerve injury: from pathological mechanisms to therapeutic targets
Optic nerve injury, encompassing conditions such as glaucoma, optic neuritis, and traumatic optic neuropathy, is a major cause of irreversible vision loss. Traditional broad-spectrum anti-inflammatory treatments have shown limited efficacy, highlighting the need for precision-based therapeutic approaches grounded in the underlying pathological mechanisms. As the primary immune cells of the central nervous system (CNS), microglia play a crucial role in regulating neuroinflammation following optic nerve injury. This review provides a comprehensive overview of the mechanisms governing microglial neuroinflammatory regulation, including early inflammatory signal recognition mediated by damage-associated molecular patterns (DAMPs), dynamic transcriptional networks regulating polarization between pro-inflammatory and pro-repair phenotypes, bidirectional modulation of phagocytic clearance by the complement system, and the complex multicellular interactions among microglia, astrocytes, and Müller cells. The concept of conditioning injury conditioning injury (intraocular inflammatory stimulation) has revealed the dual nature of neuroinflammatory responses: through temporal polarization shifts, microglia can both release neurotoxic mediators that worsen injury and secrete neurotrophic factors that promote axonal regeneration and myelin repair. This shift from traditional broad-spectrum anti-inflammatory strategies to precision functional modulation forms the basis for emerging therapeutic approaches, including PPARγ pathway activation, selective complement system targeting, and time-dependent modulation. We also assess the potential of advanced technologies, such as nanodelivery systems, single-cell analysis, and molecular imaging, in precision diagnosis and treatment. Finally, we critically examine the limitations of current research, including interspecies variability, model constraints, and clinical translation barriers, and discuss the translational potential of microglia-targeted therapies in protecting and restoring clinically meaningful visual function.
- Open Access
- 21 November 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e81328
Detection and Management of Geographic Atrophy Secondary to Age-Related Macular Degeneration Using Noninvasive Retinal Images and Artificial Intelligence: Systematic Review
Background: Geographic atrophy (GA), the endpoint of dry age-related macular degeneration (AMD), is irreversible. The recent approval by the Food and Drug Administration of a complement component 3 inhibitor marks a significant breakthrough, highlighting the critical importance of early detection and management of GA. Consequently, there is an urgent and unmet need for efficient, accurate, and accessible methods to identify and monitor GA. Artificial intelligence (AI), particularly deep learning (DL), applied to noninvasive retinal imaging, offers a promising solution for automating and enhancing GA management. Objective: This systematic review aimed to assess the performance of AI using noninvasive imaging modalities and compare it with clinical expert assessment as the ground truth. Methods: Two consecutive searches were conducted on PubMed, Embase, Web of Science, Scopus, Cochrane Library, and CINAHL. The last search was performed on October 5, 2025. Studies using AI for GA secondary to dry AMD via noninvasive retinal imaging were included. Two authors worked in pairs to extract the study characteristics independently. A third author adjudicated disagreements. Quality Assessment of Diagnostic Accuracy Studies-AI and Prediction Model Risk of Bias Assessment Tool (PROBAST) were applied to evaluate the risk of bias and application. Results: Of the 803 records initially identified, 176 were found through an updated search. Subsequently, 200 papers were assessed in full text, of which 41 were included in the final analysis, 10 for GA detection, 20 for GA assessment and progression, and 11 for GA lesion prediction. The reviewed studies collectively involved at least 24,592 participants (detection: n=7132, assessment and progression: n=14,064, and prediction: n=6706), with a wide age range of 50 to 94 years. The studies spanned a diverse array of countries, including the United States, the United Kingdom, China, Austria, Australia, France, Israel, Italy, Switzerland, and Germany, as well as a multicenter study encompassing 7 European nations. The studies used a variety of imaging modalities to assess GA, including color fundus photography, fundus autofluorescence, near-infrared reflectance, spectral domain–optical coherence tomography (OCT), swept-source (SS)-OCT, and 3D-OCT. DL algorithms (eg, U-Net, ResNet50, EfficientNetB4, Xception, Inception v3, and PSC-UNet) consistently showed remarkable performance in GA detection and management tasks, with several studies achieving performance comparable to clinical experts. Conclusions: AI, particularly DL-based algorithms, holds considerable promise for the detection and management of GA secondary to dry AMD with performance comparable to ophthalmologists. This review innovatively consolidates evidence across GA management—from initial detection to progression prediction—using diverse noninvasive imaging. It has strong potential to augment clinical decision-making. However, to realize this potential in real-world settings, future research is needed to robustly enhance reporting specifications, ensure data diversity across populations and devices, and implement rigorous external validation in prospective, multicenter studies.
- 21 November 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e81328
Open AccessDetection and Management of Geographic Atrophy Secondary to Age-Related Macular Degeneration Using Noninvasive Retinal Images and Artificial Intelligence: Systematic Review
Background: Geographic atrophy (GA), the endpoint of dry age-related macular degeneration (AMD), is irreversible. The recent approval by the Food and Drug Administration of a complement component 3 inhibitor marks a significant breakthrough, highlighting the critical importance of early detection and management of GA. Consequently, there is an urgent and unmet need for efficient, accurate, and accessible methods to identify and monitor GA. Artificial intelligence (AI), particularly deep learning (DL), applied to noninvasive retinal imaging, offers a promising solution for automating and enhancing GA management. Objective: This systematic review aimed to assess the performance of AI using noninvasive imaging modalities and compare it with clinical expert assessment as the ground truth. Methods: Two consecutive searches were conducted on PubMed, Embase, Web of Science, Scopus, Cochrane Library, and CINAHL. The last search was performed on October 5, 2025. Studies using AI for GA secondary to dry AMD via noninvasive retinal imaging were included. Two authors worked in pairs to extract the study characteristics independently. A third author adjudicated disagreements. Quality Assessment of Diagnostic Accuracy Studies-AI and Prediction Model Risk of Bias Assessment Tool (PROBAST) were applied to evaluate the risk of bias and application. Results: Of the 803 records initially identified, 176 were found through an updated search. Subsequently, 200 papers were assessed in full text, of which 41 were included in the final analysis, 10 for GA detection, 20 for GA assessment and progression, and 11 for GA lesion prediction. The reviewed studies collectively involved at least 24,592 participants (detection: n=7132, assessment and progression: n=14,064, and prediction: n=6706), with a wide age range of 50 to 94 years. The studies spanned a diverse array of countries, including the United States, the United Kingdom, China, Austria, Australia, France, Israel, Italy, Switzerland, and Germany, as well as a multicenter study encompassing 7 European nations. The studies used a variety of imaging modalities to assess GA, including color fundus photography, fundus autofluorescence, near-infrared reflectance, spectral domain–optical coherence tomography (OCT), swept-source (SS)-OCT, and 3D-OCT. DL algorithms (eg, U-Net, ResNet50, EfficientNetB4, Xception, Inception v3, and PSC-UNet) consistently showed remarkable performance in GA detection and management tasks, with several studies achieving performance comparable to clinical experts. Conclusions: AI, particularly DL-based algorithms, holds considerable promise for the detection and management of GA secondary to dry AMD with performance comparable to ophthalmologists. This review innovatively consolidates evidence across GA management—from initial detection to progression prediction—using diverse noninvasive imaging. It has strong potential to augment clinical decision-making. However, to realize this potential in real-world settings, future research is needed to robustly enhance reporting specifications, ensure data diversity across populations and devices, and implement rigorous external validation in prospective, multicenter studies.
- Open Access
- 16 December 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1423813
Artificial intelligence and glaucoma: a lucid and comprehensive review
Glaucoma is a pathologically irreversible eye illness in the realm of ophthalmic diseases. Because it is difficult to detect concealed and non-obvious progressive changes, clinical diagnosis and treatment of glaucoma is extremely challenging. At the same time, screening and monitoring for glaucoma disease progression are crucial. Artificial intelligence technology has advanced rapidly in all fields, particularly medicine, thanks to ongoing in-depth study and algorithm extension. Simultaneously, research and applications of machine learning and deep learning in the field of glaucoma are fast evolving. Artificial intelligence, with its numerous advantages, will raise the accuracy and efficiency of glaucoma screening and diagnosis to new heights, as well as significantly cut the cost of diagnosis and treatment for the majority of patients. This review summarizes the relevant applications of artificial intelligence in the screening and diagnosis of glaucoma, as well as reflects deeply on the limitations and difficulties of the current application of artificial intelligence in the field of glaucoma, and presents promising prospects and expectations for the application of artificial intelligence in other eye diseases such as glaucoma.
- 16 December 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1423813
Open AccessArtificial intelligence and glaucoma: a lucid and comprehensive review
Glaucoma is a pathologically irreversible eye illness in the realm of ophthalmic diseases. Because it is difficult to detect concealed and non-obvious progressive changes, clinical diagnosis and treatment of glaucoma is extremely challenging. At the same time, screening and monitoring for glaucoma disease progression are crucial. Artificial intelligence technology has advanced rapidly in all fields, particularly medicine, thanks to ongoing in-depth study and algorithm extension. Simultaneously, research and applications of machine learning and deep learning in the field of glaucoma are fast evolving. Artificial intelligence, with its numerous advantages, will raise the accuracy and efficiency of glaucoma screening and diagnosis to new heights, as well as significantly cut the cost of diagnosis and treatment for the majority of patients. This review summarizes the relevant applications of artificial intelligence in the screening and diagnosis of glaucoma, as well as reflects deeply on the limitations and difficulties of the current application of artificial intelligence in the field of glaucoma, and presents promising prospects and expectations for the application of artificial intelligence in other eye diseases such as glaucoma.
- Open Access
- 23 September 2024
- Published by Wolters Kluwer Health in World Journal of Traditional Chinese Medicine
- Vol. 10 (4) , 548-560
Exploring the Protective Effects of Xueshuantong Injection on Central Retinal Vein Occlusion
Objective: This study aimed to assess the therapeutic effects of Xueshuantong (XST), a traditional Chinese medicine that has been studied for its protective effects on the cardiovascular system and anti-inflammatory properties, on central retinal vein occlusion (CRVO) in rabbits and rats. Materials and Methods: CRVO was induced in rabbits and rats by laser photocoagulation. The animals were then treated with different doses of XST or lyophilized XST (L). Color fundus photography, fundus fluorescein angiography, histological examination, TUNEL assay, and immunofluorescence staining were conducted to evaluate the therapeutic effects. Results: The study revealed that both XST and lyophilized XST injections exhibited therapeutic effects against CRVO in rabbits and rats. The drugs improved retinal lesions and structure and mitigated apoptosis of retinal cells to varying degrees. Additionally, downregulation of tumor necrosis factor-α and interleukin-6 within the retina was observed in both drug groups. Conclusions: The results indicate that XST injection exhibited significant protective effects against experimental CRVO by regulating angiogenesis and inflammation, suggesting its potential as an effective therapeutic strategy for treating CRVO.
- 23 September 2024
- Published by Wolters Kluwer Health in World Journal of Traditional Chinese Medicine
- Vol. 10 (4) , 548-560
Open AccessExploring the Protective Effects of Xueshuantong Injection on Central Retinal Vein Occlusion
Objective: This study aimed to assess the therapeutic effects of Xueshuantong (XST), a traditional Chinese medicine that has been studied for its protective effects on the cardiovascular system and anti-inflammatory properties, on central retinal vein occlusion (CRVO) in rabbits and rats. Materials and Methods: CRVO was induced in rabbits and rats by laser photocoagulation. The animals were then treated with different doses of XST or lyophilized XST (L). Color fundus photography, fundus fluorescein angiography, histological examination, TUNEL assay, and immunofluorescence staining were conducted to evaluate the therapeutic effects. Results: The study revealed that both XST and lyophilized XST injections exhibited therapeutic effects against CRVO in rabbits and rats. The drugs improved retinal lesions and structure and mitigated apoptosis of retinal cells to varying degrees. Additionally, downregulation of tumor necrosis factor-α and interleukin-6 within the retina was observed in both drug groups. Conclusions: The results indicate that XST injection exhibited significant protective effects against experimental CRVO by regulating angiogenesis and inflammation, suggesting its potential as an effective therapeutic strategy for treating CRVO.
- Open Access
- 27 August 2024
- Published by Elsevier in Experimental Gerontology
- Vol. 196
Exploring the protective effects of Qiju Granule in a rat model of dry age-related macular degeneration
- 27 August 2024
- Published by Elsevier in Experimental Gerontology
- Vol. 196
Open AccessExploring the protective effects of Qiju Granule in a rat model of dry age-related macular degeneration
- Open Access
- 8 August 2024
- Published by Elsevier in European Journal of Integrative Medicine
- Vol. 71
Methodological quality evaluation of animal experiments on traditional Chinese medicine formulas for glaucoma: A systematic review
- 8 August 2024
- Published by Elsevier in European Journal of Integrative Medicine
- Vol. 71
Open AccessMethodological quality evaluation of animal experiments on traditional Chinese medicine formulas for glaucoma: A systematic review